Table Graph
      published meta-analysis   sensitivity analysis   studies

angiotensin receptor blockers (ARBs) in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsUniversity of Minnesota, 2020 1.29 [0.51; 3.26] 1.29[0.51; 3.26]University of Minnesota, 202010%205NAnot evaluable death or transfer to ICUdetailed resultsDuarte, 2020 0.57 [0.18; 1.79] 0.57[0.18; 1.79]Duarte, 202010%78NAnot evaluable deathsdetailed resultsCOVID MED (losartan), 2021 3.20 [0.25; 41.21] Duarte, 2020 0.45 [0.08; 2.60] University of Minnesota, 2020 0.68 [0.11; 4.16] 0.77[0.25; 2.40]COVID MED (losartan), 2021, Duarte, 2020, University of Minnesota, 202030%297moderatenot evaluable hospital dischargedetailed resultsDuarte, 2020 2.15 [1.18; 3.93] University of Minnesota, 2020 0.64 [0.37; 1.11] 1.17[0.35; 3.84]Duarte, 2020, University of Minnesota, 2020288%283moderatenot evaluable hospitalizationdetailed resultsUniversity of Minnesota, 2020 1.63 [0.94; 2.85] 1.63[0.94; 2.85]University of Minnesota, 202010%205NAnot evaluable mechanical ventilationdetailed resultsDuarte, 2020 0.30 [0.03; 3.01] University of Minnesota, 2020 1.34 [0.66; 2.73] 0.96[0.28; 3.28]Duarte, 2020, University of Minnesota, 2020233%281moderatenot evaluable ICU admissiondetailed resultsDuarte, 2020 0.73 [0.18; 2.97] 0.73[0.18; 2.97]Duarte, 202010%78NAnot evaluable0.25.01.0relative treatment effectwww.metaEvidence.org2024-04-28 01:49 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 590,891 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons